Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
giuseppe.giannini@uniroma1.it
Giuseppe Giannini
Professore Ordinario
Struttura:
DIPARTIMENTO DI MEDICINA MOLECOLARE
E-mail:
giuseppe.giannini@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2024
Prenatal Alcohol Exposure and Metabolic Disorders in Pediatrics: The Role of the Oxidative Stress—A Review of the Literature
CHILDREN
2024
Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology
FRONTIERS IN ONCOLOGY
2023
Combined inhibition of polyamine metabolism and eIF5A hypusination suppresses colorectal cancer growth through a converging effect on MYC translation
CANCER LETTERS
2023
Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer
FRONTIERS IN ONCOLOGY
2023
Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study
EUROPEAN JOURNAL OF CANCER
2023
The Multiple Faces of the MRN Complex: Roles in Medulloblastoma and Beyond
CANCERS
2023
SALL4 is a CRL3^REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma
CELL DEATH AND DIFFERENTIATION
2023
Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions
FRONTIERS IN IMMUNOLOGY
2023
FACILITATE: A real-world, multicenter, prospective study investigating the utility of a rapid, fully automated real-time PCR assay versus local reference methods for detecting epidermal growth factor receptor variants in NSCLC
PATHOLOGY ONCOLOGY RESEARCH
2023
A single-cell transcriptomic analysis of Neuroblastomas revealed a selective cGAS-STING pathway suppression in malignant cells
PROCEEDINGS IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE
2023
RAS mutation conversion in bevacizumab-treated metastatic colorectal cancer patients: a liquid biopsy based study
CANCERS
2022
An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy
BIOLOGY DIRECT
2022
A gene dosage‐dependent effect unveils NBS1 as both a haploinsufficient tumour suppressor and an essential gene for SHH‐medulloblastoma
NEUROPATHOLOGY & APPLIED NEUROBIOLOGY
2022
5FU/Oxaliplatin-induced Jagged1 cleavage counteracts apoptosis induction in colorectal cancer: a novel mechanism of intrinsic drug resistance
FRONTIERS IN ONCOLOGY
2022
True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature
CANCER LETTERS
2021
A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors
ONCOGENE
2021
A multidisciplinary approach for the differential diagnosis between multiple primary lung adenocarcinomas and intrapulmonary metastases
PATHOLOGY RESEARCH AND PRACTICE
2021
Comparison of two blood-based genotyping tests to investigate the KRAS G12C mutation in patients with non-small-cell lung cancer at failure of first-line treatments
DIAGNOSTICS
2021
Transcriptome of male breast cancer matched with germline profiling reveals novel molecular subtypes with possible clinical relevance
CANCERS
2021
1
2
3
4
seguente ›
ultima »
Progetti di Ricerca
Dissecting the role of the Nijmegen breakage syndrome protein in SHH-dependent tumorigenesis
Repressing or enhancing replication stress: the two sides of the coin to understand and tackle MYCN-dependent tumors.
Laboratori di ricerca
LABORATORIO BIOCHIMICO BIOLOGICO LIV BIOSICUREZZA 1 224 225
LABORATORIO BIOCHIMICO BIOLOGICO LIV BIOSICUREZZA 1 208
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma